Rasmus Kjeldsen Jensen

Aarhus University

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (12)

Morten Krogh Herlin

Aarhus University

DENMARK

View details

Per Höllsberg

DENMARK

View details

Vivien Schack

Aarhus University

DENMARK

View details

Uffe Birk Jensen

Aarhus University

DENMARK

View details

Christian Möbs

GERMANY

View details

Gregers Rom Andersen

Aarhus University

DENMARK

View details

Steen Vang Petersen

Aarhus University

DENMARK

View details

Thomas Vorup-Jensen

Aarhus University

DENMARK

View details

Nick Stub Laursen

Aarhus University

DENMARK

View details

Jens Magnus Bernth Jensen

Aarhus University

DENMARK

View details

József Dobó

Research Centre for Natural Sciences

HUNGARY

View details

Jan Johannes Enghild

Professor

Aarhus University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rasmus Kjeldsen Jensen

Research Interests

Explore related searches

Contact this professor

Articles (9)

Novel homozygous CD46 variant with C-isoform expression affects C3b inactivation in atypical hemolytic uremic syndrome

Structural insights into the function-modulating effects of nanobody binding to the integrin receptor αMβ2

Structure-Guided Engineering of a Complement Component C3-Binding Nanobody Improves Specificity and Adds Cofactor Activity

ITIH4 acts as a protease inhibitor by a novel inhibitory mechanism

Complement Receptor 3 Forms a Compact High-Affinity Complex with iC3b

A Complement C3–Specific Nanobody for Modulation of the Alternative Cascade Identifies the C-Terminal Domain of C3b as Functional in C5 Convertase Activity

Complement activation by human IgG antibodies to galactose-alpha-1,3-galactose.

A C3-specific nanobody that blocks all three activation pathways in the human and murine complement system.

Structure of intact IgE and the mechanism of ligelizumab revealed by electron microscopy

Collaborators (12)

Morten Krogh Herlin

Per Höllsberg

Vivien Schack

Uffe Birk Jensen

Christian Möbs

Gregers Rom Andersen

Steen Vang Petersen

Thomas Vorup-Jensen

Nick Stub Laursen

Jens Magnus Bernth Jensen

József Dobó

Jan Johannes Enghild

Make your next move.